AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
44 hedge funds and large institutions have $25.7M invested in AVEO Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
44
Holding in Top 10
2
Calls
$57K
Puts
–
Top Buyers
| 1 | +$169K | |
| 2 | +$39K | |
| 3 | +$17K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$15K |
| 5 |
Goldman Sachs
New York
|
+$15K |
Top Sellers
| 1 | -$498K | |
| 2 | -$249K | |
| 3 | -$92K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$53.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$44.4K |